‘Possible’ GLP-1 effects in substance use disorders


Despite “lots of interest” in possible reductions in alcohol and smoking, cost and side effects may present barriers to using popular weight loss drugs in addiction medicine Major studies have shown possible effects of GLP-1 receptor agonists in alcohol and smoking reduction, but there are barriers to its uptake, said experts at a recent leading

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Evidence ‘weak’ behind medicinal cannabis for insomnia
Next ‘Let’s be serious’: Liberals take aim at vape laws